Spero Therapeutics, Inc. (SPRO)
2.59
+0.01
(+0.39%)
USD |
NASDAQ |
May 19, 16:00
2.59
0.00 (0.00%)
Pre-Market: 08:10
Spero Therapeutics EPS Diluted (TTM) : 0.2436 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| SELLAS Life Sciences Group, Inc. | -0.2283 |
| Lantern Pharma, Inc. | -1.445 |
| ACADIA Pharmaceuticals, Inc. | 2.196 |
| Alnylam Pharmaceuticals, Inc. | 4.209 |
| Amgen, Inc. | 14.38 |